Cell Therapy Targets for Autism Spectrum Disorders: Hopes, Challenges and Future Directions.
Bagher LarijaniNajmeh Foroughi HeravaniSepideh Alavi-MoghadamParisa GoodarziMostafa Rezaei TaviraniMoloud PayabMahdi GholamiFarideh RaziBabak ArjmandPublished in: Advances in experimental medicine and biology (2021)
Autism spectrum disorders as a group of pediatric neurodevelopmental diseases is a crucial part of the worldwide disabilities which have influence in communication skills, social interactions, and ability to understand the concepts. The precise pathophysiology of autism spectrum disorders due to the abundance of involved mechanisms is unknown. Some of these involved mechanisms are related to genetic factors, chronic neuro inflammation, mitochondrial dysfunction, oxidative stress, immune dysregulation, hormonal imbalance, and environmental factors. Current main treatments for autisms are behavioral, nutritional and medical therapies, however there is not definitive treatment approach. Therein, more novel therapies are still required to improve the symptoms. Several preclinical and clinical evidence were shown that stem cell therapy is a potential treatment option for autism spectrum disorders individuals. Considering the significant factors which can affect the outcome of stem cell therapeutic effects including stem cell types, route and dosage of administration, and mechanism of activity along with selecting best animal models can be very important in performing clinical trials.
Keyphrases
- cell therapy
- autism spectrum disorder
- stem cells
- oxidative stress
- clinical trial
- mesenchymal stem cells
- attention deficit hyperactivity disorder
- healthcare
- intellectual disability
- squamous cell carcinoma
- adipose tissue
- mental health
- radiation therapy
- ischemia reperfusion injury
- skeletal muscle
- risk assessment
- dna damage
- gene expression
- combination therapy
- congenital heart disease
- depressive symptoms
- polycystic ovary syndrome
- type diabetes
- genome wide
- insulin resistance
- induced apoptosis
- wastewater treatment
- locally advanced
- drug induced
- placebo controlled
- heat shock protein